Delisting risk
Quince Therapeutics (QNCX)
Develops inhaled sirolimus for pulmonary hypertension and bronchiolitis obliterans syndrome.
$31.61
Pre-market−0.94 (−2.89%)
At close$32.55(+1.37%)
Something off on this page? Send us feedback.
Next report
Nov 11, 2026
in 69 days
EPS estimate
−$4.03
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Nov '25Apr '26Apr '26May '26May '26Aug '26Aug '26Nov '26
Reported−$50.00−$3.50−$4.30−$0.59$75.60−$12.31−$12.31Pending
Estimate−$40.00−$3.59−$0.18−$1.30−$26.00−$28.02−$28.02−$4.03
Surprise−25.0%+2.6%−2,292.9%+54.6%+390.8%+56.1%+56.1%—
RevenueReportedEstimate
Nov '25Apr '26Apr '26May '26May '26Aug '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$4.03 | — | — |
| Aug 2026 | −$28.02 | −$12.31 | +56.1% |
| Aug 2026 | −$28.02 | −$12.31 | +56.1% |
| May 2026 | −$26.00 | $75.60 | +390.8% |
| May 2026 | −$1.30 | −$0.59 | +54.6% |
The latest year is open to everyone — the 34 quarters behind it read with an account. Sign in | |||
| Apr 2026 | |||
| Apr 2026 | |||
| Nov 2025 | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Apr 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| Jun 2019 | |||
| May 2019 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 11, 2026 | −$4.03 | — | — | — | — | — | — |
| Aug 14, 2026 | −$28.02 | −$12.31 | +56.1% | — | — | — | +5.0% |
| Aug 13, 2026 | −$28.02 | −$12.31 | +56.1% | — | — | — | +3.7% |
| May 12, 2026 | −$26.00 | $75.60 | +390.8% | — | — | — | −3.2% |
| May 11, 2026 | −$1.30 | −$0.59 | +54.6% | — | — | — | +1.6% |
The latest year is open to everyone — the 34 quarters behind it read with an account. Sign in | |||||||
| Apr 10, 2026 | |||||||
| Apr 6, 2026 | |||||||
| Nov 12, 2025 | |||||||
| Aug 11, 2025 | |||||||
| May 13, 2025 | |||||||
| Mar 24, 2025 | |||||||
| Nov 13, 2024 | |||||||
| Aug 13, 2024 | |||||||
| May 13, 2024 | |||||||
| Apr 1, 2024 | |||||||
| Mar 11, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Aug 3, 2023 | |||||||
| May 15, 2023 | |||||||
| Mar 15, 2023 | |||||||
| Nov 9, 2022 | |||||||
| Aug 9, 2022 | |||||||
| May 10, 2022 | |||||||
| Mar 1, 2022 | |||||||
| Nov 11, 2021 | |||||||
| Aug 9, 2021 | |||||||
| May 6, 2021 | |||||||
| Mar 1, 2021 | |||||||
| Nov 12, 2020 | |||||||
| Aug 14, 2020 | |||||||
| May 12, 2020 | |||||||
| Mar 16, 2020 | |||||||
| Nov 12, 2019 | |||||||
| Aug 9, 2019 | |||||||
| Jun 12, 2019 | |||||||
| May 9, 2019 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 | |||||||